Sign in
BNBX Stock Price, Chart, Stats & News
BNB Plus Corp.
Save
BNB Plus Corp. (BNBX) does not currently pay a dividend.
435,189
Market cap
0.01x
Current P/E
158.73x
Forward P/E
BNBX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 23.12% |
Operating margin | -1298.09% |
Pretax margin | -1541.71% |
Net margin | -1515.88% |
Effective tax rate | 2.16% |
ROA | -150.33% |
ROE | -320.25% |
D/E | 0.00x |
Interest coverage ratio | – |
BNBX valuation
P/E | 0.01x |
P/S | 0.43x |
P/B | 0.33x |
P/CF | -0.41x |
P/FCF | -0.06x |
P/OCF | -0.41x |
PEG | -0.00x |
EV multiple | -0.13x |
About
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production.
Similar securities
Based on sector and market capitalization
Report issue